Providers

BridgeBio is a biotechnology company designing transformative medicines for patients with genetic diseases and cancers with clear genetic drivers.

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi)…

Sara N. Horst, MD, MPH is an Associate Professor at Vanderbilt University Medical Center (VUMC) and a gastroenterologist who is interested in the care of patients…

In February last year, Doherty - now about age 65 - began to experience the same early breathing symptoms his father had had. As an avid hiker who has trekked the…